$25.45
-1.02-3.85%
Dern. MÀJ: Oct 6, 4:00 PM
$25.45
-1.02-3.85%
Neurogene (NGNE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.38 | $-1.29 | $-1.21 | $-1.16 |
| Actual | $-1.53 | $-1.39 | $-1.13 | $-0.99 |
| Surprise | -10.9% | -7.75% | +6.61% | +14.7% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.43 | $-1.38 | $-1.22 | $-1.24 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-1.53 | $-1.38 | -10.9 % |
| Q1 | May 12, 2026 | $-1.39 | $-1.29 | -7.75 % |
| Q4 | Mar 24, 2026 | $-1.13 | $-1.21 | 6.61 % |
| Q3 | Nov 13, 2025 | $-0.99 | $-1.16 | 14.7 % |